We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATOS market cap is 190.46M. The company's latest EPS is USD -0.2402 and P/E is -6.33.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.21M | -8.14M | -7.1M | -7.79M | -7.47M |
| Net Income | -8.01M | -7.49M | -6.28M | -9.83M | -6.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.27M | -15.55M | -20.61M | -27.69M | -31.38M |
| Net Income | -17.24M | -22.33M | -20.61M | -26.96M | -30.09M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 126.72M | 123.53M | 116.2M | 108.36M | 101.7M |
| Total Liabilities | 2.87M | 5.57M | 2.94M | 3.48M | 3.44M |
| Total Equity | 123.86M | 117.96M | 113.26M | 104.88M | 98.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.49M | 42.84M | 141.26M | 123.53M | 96.25M |
| Total Liabilities | 1.33M | 15.67M | 3.13M | 5.57M | 5.24M |
| Total Equity | 13.16M | 27.17M | 138.14M | 117.96M | 91.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.24M | -20.76M | -7.02M | -11.49M | -15.37M |
| Investing | -2.72M | -4.73M | N/A | -13k | -14k |
| Financing | N/A | N/A | N/A | N/A | -1.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.13M | -11.57M | -16.47M | -20.76M | -20.94M |
| Investing | -8k | -9k | -9k | -4.73M | -14k |
| Financing | 11.34M | 38.55M | 113.3M | N/A | -1.48M |
| Market Cap | 190.46M |
| Price to Earnings Ratio | -6.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.15 |
| Price to Book Ratio | 2.09 |
| Dividend Yield | - |
| Shares Outstanding | 125.3M |
| Average Volume (1 week) | 1.32M |
| Average Volume (1 Month) | 2.47M |
| 52 Week Change | 134.21% |
| 52 Week High | 2.31 |
| 52 Week Low | 0.60 |
| Spread (Intraday) | 0.01 (0.66%) |
| Company Name | Atossa Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atossatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
